Exploring the Utility of NK Cells in COVID-19

Exploring the Utility of NK Cells in COVID-19

Coronavirus disease 2019 (COVID-19) can manifest as acute respiratory distress syndrome and is associated with substantial morbidity and mortality. Extensive data now indicate that immune responses to SARS-CoV-2 infection determine the COVID-19 disease course. A wide range of immunomodulatory agents...

Full description

Bibliographic Details
Main Authors:	Xuewen Deng, Hiroshi Terunuma, Mie Nieda
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Biomedicines
Subjects:	SARS-CoV-2 COVID-19 NK cell immune dysregulation immunotherapy
Online Access:	https://www.mdpi.com/2227-9059/10/5/1002

Similar Items

Immunosurveillance of Cancer and Viral Infections with Regard to Alterations of Human NK Cells Originating from Lifestyle and Aging
by: Xuewen Deng, et al.
Published: (2021-05-01)

Harnessing NK Cells to Control Metastasis
by: Xuewen Deng, et al.
Published: (2022-11-01)

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
by: Ceri Alan Fielding, et al.
Published: (2022-05-01)

NK cells from COVID-19 positive patients exhibit enhanced cytotoxic activity upon NKG2A and KIR2DL1 blockade
by: Grace Lee, et al.
Published: (2023-07-01)

Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
by: Roberta Rovito, et al.
Published: (2022-06-01)

Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
by: Ali A. Rabaan, et al.
Published: (2021-05-01)

Can there be calm during a cytokine storm? Immune checkpoint pathways affecting the severity of COVID-19 disease
by: Matyas Meggyes, et al.
Published: (2024-12-01)

COVID-19 and Progesterone: Part 1. SARS-CoV-2, Progesterone and its potential clinical use
by: Shilpa Bhuaptrai Shah
Published: (2021-12-01)

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
by: Renuka Raman, et al.
Published: (2021-07-01)

The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions
by: Anahid Jewett, et al.
Published: (2020-07-01)

Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
by: Jon Hazeldine, et al.
Published: (2021-06-01)

Hematological Complications in a COVID-19 Patient: A Case Report
by: Eleonora Ianuà, et al.
Published: (2023-12-01)

Expansion of CD56<sup>dim</sup>CD16<sup>neg</sup> NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients
by: José L. Casado, et al.
Published: (2021-12-01)

Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza
by: Demi Brownlie, et al.
Published: (2022-03-01)

Editorial: Definition of the immune parameters related to COVID-19 severity
by: Camilla Tincati, et al.
Published: (2023-04-01)

Predicting progression to severe COVID-19 using the PAINT score
by: Ming Wang, et al.
Published: (2022-05-01)

Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19
by: Letizia Vitali, et al.
Published: (2022-10-01)

Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
by: Bastian Fischer, et al.
Published: (2021-08-01)

Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients
by: Judith Abarca-Zabalía, et al.
Published: (2023-02-01)

High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation
by: Sarah M. McAlpine, et al.
Published: (2021-05-01)

NK cells in renal cell carcinoma and its implications for CAR-NK therapy
by: Xinwei Li, et al.
Published: (2025-02-01)

Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence
by: Francisco Fuentes-Villalobos, et al.
Published: (2022-02-01)

TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cells
by: Nadine Landolina, et al.
Published: (2024-05-01)

Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators
by: Monica D. Reece, et al.
Published: (2021-11-01)

Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics
by: Xuewen Deng, et al.
Published: (2024-06-01)

SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis
by: Marzena Lenart, et al.
Published: (2023-05-01)

Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
by: Barbara Seliger, et al.
Published: (2022-08-01)

Editorial: Women in NK and innate lymphoid cell biology
by: Alessandra Zingoni, et al.
Published: (2023-02-01)

Overview of Memory NK Cells in Viral Infections: Possible Role in SARS-CoV-2 Infection
by: Juan Bautista De Sanctis, et al.
Published: (2022-01-01)

Post‐COVID‐19 pulmonary fibrosis: Mechanisms, biomarkers, and therapeutic perspectives
by: Urvinder Kaur Sardarni, et al.
Published: (2025-02-01)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
by: Xinyu Wu, et al.
Published: (2022-12-01)

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer
by: Loredana Cifaldi, et al.
Published: (2020-06-01)

Recent Chronology of COVID-19 Pandemic
by: Sazada Siddiqui, et al.
Published: (2022-05-01)

The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
by: J.L. Boechat, et al.
Published: (2021-09-01)

Characteristics and Outcomes of Cryptococcosis among Patients with and without COVID-19
by: Daniel B. Chastain, et al.
Published: (2022-11-01)

Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation
by: Benjamin Bonnet, et al.
Published: (2021-11-01)

NK cell-based tumor immunotherapy
by: Hao Zhang, et al.
Published: (2024-01-01)

Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection
by: Maren Claus, et al.
Published: (2023-08-01)

Immune dysregulation in COVID-19 and its therapeutic implications
by: T Praveen, et al.
Published: (2020-01-01)

Immunomodulation of NK Cells by Ionizing Radiation
by: Jiarui Chen, et al.
Published: (2020-06-01)